InvestorsObserver
×
News Home

Is 10X Genomics Inc (TXG) a Good Buy in the Health Information Services Industry?

Friday, February 24, 2023 02:23 PM | InvestorsObserver Analysts

Mentioned in this article

Is 10X Genomics Inc (TXG) a Good Buy in the Health Information Services Industry?

10X Genomics Inc (TXG) is near the middle in its industry group according to InvestorsObserver. TXG gets an overall rating of 44. That means it scores higher than 44 percent of stocks. 10X Genomics Inc gets a 58 rank in the Health Information Services industry. Health Information Services is number 100 out of 148 industries.

Overall Score - 44
TXG has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on TXG!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With 10X Genomics Inc Stock Today?

10X Genomics Inc (TXG) stock is trading at $47.04 as of 2:22 PM on Friday, Feb 24, a decline of -$0.97, or -2.03% from the previous closing price of $48.01. The stock has traded between $45.96 and $47.99 so far today. Volume today is less active than usual. So far 368,682 shares have traded compared to average volume of 1,128,014 shares. Click Here to get the full Stock Report for 10X Genomics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App